Cargando…
Novel serotonin 5-HT(2A) receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents
BACKGROUND: Antiplatelet drugs have been used in the treatment of acute coronary syndromes and for the prevention of recurrent events. Unfortunately, many patients remain resistant to the available antiplatelet treatment. Therefore, there is a clinical need to synthesize novel antiplatelet agents, w...
Autores principales: | Czopek, Anna, Kubacka, Monika, Bucki, Adam, Siwek, Agata, Filipek, Barbara, Pawłowski, Maciej, Kołaczkowski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460535/ https://www.ncbi.nlm.nih.gov/pubmed/34115343 http://dx.doi.org/10.1007/s43440-021-00284-6 |
Ejemplares similares
-
Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives
por: Czopek, Anna, et al.
Publicado: (2020) -
[4+2]-Cycloaddition to 5-Methylidene-Hydantoins and 5-Methylidene-2-Thiohydantoins in the Synthesis of Spiro-2-Chalcogenimidazolones
por: Shybanov, Dmitry E., et al.
Publicado: (2023) -
Serotonin 5-HT(6) Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease
por: Więckowski, Krzysztof, et al.
Publicado: (2022) -
Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
por: Dudek, Magdalena, et al.
Publicado: (2015) -
Mechanistic Studies on the Stereoselectivity of the Serotonin 5‐HT(1A) Receptor
por: Yuan, Shuguang, et al.
Publicado: (2016)